Neftaly: Fever of Unknown Origin (FUO) Management
Introduction
Fever of Unknown Origin (FUO) is defined as a prolonged fever (≥38.3°C / 101°F) lasting more than 3 weeks, with no diagnosis after 1 week of inpatient investigation or equivalent outpatient evaluation. FUO represents a diagnostic challenge due to the wide range of potential underlying causes, including infections, inflammatory disorders, malignancies, and miscellaneous conditions. Early and systematic evaluation is critical to identify treatable causes and avoid unnecessary interventions.
Etiology
FUO can broadly be classified into four categories:
- Infectious Causes (≈30–40%)
- Endocarditis
- Tuberculosis
- Abscesses (hepatic, intra-abdominal)
- Viral infections (EBV, CMV, HIV)
- Non-Infectious Inflammatory Disorders (≈20–30%)
- Connective tissue diseases (SLE, vasculitis)
- Adult-onset Still’s disease
- Temporal arteritis
- Neoplastic Causes (≈10–20%)
- Lymphomas
- Leukemias
- Solid organ tumors
- Miscellaneous and Undiagnosed Causes (≈10–20%)
- Drug fever
- Factitious fever
- Thyroid disorders
Initial Assessment
1. Detailed History
- Fever pattern and duration
- Travel, occupational, or exposure history
- Drug history
- Past medical history including immunosuppression
- Family and social history
2. Comprehensive Physical Examination
- Full systemic examination including lymph nodes, skin, joints, and abdomen
- Signs of endocarditis, hepatosplenomegaly, rashes, or vasculitis
Laboratory and Imaging Workup
Basic Initial Tests
- CBC with differential
- ESR/CRP
- Blood cultures (≥3 sets)
- Urinalysis and urine cultures
- Liver and renal function tests
- Chest X-ray
Extended Workup (if undiagnosed after initial evaluation)
- Serologies (HIV, EBV, CMV, hepatitis)
- Autoimmune markers (ANA, RF, ANCA)
- Imaging: CT chest/abdomen/pelvis or PET-CT for occult malignancy or abscess
- Bone marrow biopsy if hematologic malignancy suspected
Management Principles
- Treat Underlying Cause:
Directed therapy is based on the identified etiology. For example:- Antibiotics for confirmed bacterial infections
- Immunosuppressive therapy for autoimmune disorders
- Oncologic treatment for malignancies
- Symptomatic Management:
- Antipyretics (paracetamol, NSAIDs) for comfort
- Hydration and nutrition support
- Empirical Therapy:
- Reserved for critically ill patients or those with suspected infections where delay could be harmful
- Broad-spectrum antibiotics may be considered if sepsis is suspected
- Follow-Up and Monitoring:
- Regular reassessment with repeat labs and imaging if fever persists
- Monitor for complications and treatment response
Red Flags Requiring Urgent Action
- Signs of sepsis or hemodynamic instability
- Rapidly progressive weight loss
- Severe immunosuppression
- New neurological deficits or organ dysfunction
Key Points
- FUO is a diagnostic challenge requiring a structured, stepwise approach
- Thorough history, physical examination, and targeted investigations are essential
- Management should be etiology-specific; empirical therapy is rarely first-line
- Multidisciplinary involvement (infectious disease, rheumatology, hematology/oncology) may improve outcomes
This content can also be formatted into Neftaly modules with checklists, flowcharts, and case-based scenarios for practical application.



